Establishing the role of angiotensin-converting enzyme in renal function and blood pressure control through the analysis of genetically modified mice

Journal of the American Society of Nephrology

Volumn 16, Issue 3, 2005, Pages 583-591

  Bernstein, Kenneth E ^a   Xiao, Hong D ^a   Adams, Jon W ^a   Frenzel, Kristen ^a   Li, Ping ^a   Shen, Xiao Z ^a   Cole, Justin M ^a   Fuchs, Sebastien ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; KIDNEY ENZYME;

BLOOD PRESSURE REGULATION; DNA MODIFICATION; ENZYME LOCALIZATION; HEART; KIDNEY FUNCTION; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; ENZYMOLOGY; GENETICS; KIDNEY; METABOLISM; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; RENOVASCULAR HYPERTENSION;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HYPERTENSION, RENAL; KIDNEY; MICE; MICE, KNOCKOUT; PEPTIDYL-DIPEPTIDASE A;

EID: 20544456187     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004080693     Document Type: Review

References (40)

1. Harrison DG, Cai H, Landmesser U, Griendling KK: Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003
2. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10: 321-395, 2001
3. Capecchi MR: Targeted gene replacement. Sci Am 270: 34-41, 1994
4. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K: Angiotensinogen-deficient mice with hypotension. J Biol Chem 269: 31334-31337, 1994
5. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 92: 2735-2739, 1995
6. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375: 146-148, 1995
7. Esther CR, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74: 953-966, 1996
8. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Fogo A, Utsunomiya H, Inagami T, Ichikawa I: Murine double nullizygotes of the angiotensin type IA and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998
9. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM: Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95: 15496-15501, 1998
10. Hagaman JR, Moyer JS, Bachman ES, Sibony M, Magyar PL, Welch JE, Smithies O, Krege JH, O'Brien DA: Angiotensin-converting enzyme and male fertility. Proc Natl Acad Sci U S A 95: 2552-2557, 1998
11. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, et al: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71: 169-180, 1992
12. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330: 1629-1633, 1994
13. Corvol P, Williams TA, Soubrier F: Peptidyl dipeptidase A: Angiotensin I-converting enzyme. Methods Enzymol 248: 283-305, 1995
14. Frindel E, Guigon M: Inhibition of CFU entry into cycle by a bone marrow extract. Exp Hematol 5: 74-76, 1977
15. Yang F, Yang XP, Liu YH, Xu J, Cingolani O, Rhaleb NE, Carretero OA: Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension 43: 229-236, 2004
16. 5 Rousseau A, Michaud A, Chauvet MT, Lenfant M, Corvol P: The hemoregulatory peptide n-acetyl-ser-asp-lys-pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem 270: 3656-3661, 1995
17. Fuchs S, Xiao HD, Cole JM, Adams JW, Frenzel K, Michaud A, Zhao H, Keshelava G, Capecchi MR, Corvol P, Bernstein KE: Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice. J Biol Chem 279: 15946-15953, 2004
18. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, Capecchi M, Corvol P, Bernstein KE: Mice deficient in angiotensin converting enzyme (ACE) have anemia due to a lack of angiotensin II facilitated erythropoiesis. J Clin Invest 106: 1391-1398, 2000
19. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE: Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 90: 87-92, 2002
20. Cole J, Khokhlova N, Sutliff RL, Adams JW, Disher KM, Zhao H, Capecchi MR, Corvol P, Bernstein KE: Mice lacking endothelial angiotensin-converting enzyme (ACE): Normal blood pressure with elevated angiotensin II. Hypertension 41: 313-321, 2003
21. Xiao HD, Fuchs S, Campbell DJ, Lewis W, Dudley SC Jr, Kasi VS, Hoit BD, Keshelava GT, Zhao H, Capecchi MR, Bernstein KE: Mice with cardiac restricted angiotensin converting enzyme (ACE) have atrial enlargement and sudden death. Am J Pathol 165: 1019-1032, 2004
22. Smithies O, Kim H-S, Takahashi N, Edgell MH: Importance of quantitative genetic variations in the etiology of hypertension. Kidney Int 58: 2265-2280, 2000
23. Xiao HD, Fuchs S, Cole JM, Disher KM, Sutliff RL, Bernstein KE: The role of bradykinin in angiotensin-converting enzyme (ACE) knockout mice. Am J Physiol 284: H1969-H1977, 2003
24. Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, Polgar P: Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 193: 275-286, 2002
25. Dzau VJ: Multiple pathways of angiotensin production in the blood vessel wall: Evidence, possibilities, and hypotheses. J Hypertens 7: 933-936, 1989
26. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, Weber M; Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy: The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data. Am J Cardiol 88: 1L-20L, 2001
27. Campbell DJ, Alexiou T, Hong HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE: Effect of reduced ACE gene expression and ACE inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43: 854-859, 2004
28. Wei CC, Tian B, Perry G, Meng QC, Chen YF, Oparil S, Dell'Italia LJ: Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am J Physiol 282: H2254-H2258, 2002
29. Navar LG, Imig JD, Zou L, Wang CT: Intrarenal production of angiotensin II. Semin Nephrol 17: 412-422, 1997
30. Ding Y, Davisson RL, Hardy DO, Zhu LJ, Merrill DC, Catterall JF, Sigmund CD: The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 272: 28142-28148, 1997
31. Ding Y, Sigmund CD: Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol 280: F54-F60, 2001
32. Quaggin S: A "molecular toolbox" for the nephrologist. J Am Soc Nephrol 13: 1682-1685, 2002
33. Sepulveda AR, Huang SL, Lebovitz RM, Lieberman MW: A 346-base pair region of the mouse gamma-grutamyl transpeptidase type II promoter contains sufficient cis-acting elements for kidney-restricted expression in transgenic mice. J Biol Chem 272: 11959-11967, 1997
34. Schaffner DL, Barrios R, Massey C, Banez EI, Ou CN, Rajagopalan S, Aguilar-Cordova E, Lebovitz RM, Overbeek PA, Lieberman MW: Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 142: 1051-1060, 1993
35. Zhu X, Cheng J, Gao J, Lepor H, Zhang ZT, Pak J, Wu XR: Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice. Am J Physiol 282: F608-F617, 2002
36. Cole JM, Xiao H, Adams JW, Disher KM, Zhao H, Bernstein KE: New approaches to genetic manipulation of mice: Tissue-specific expression of ACE. Am J Physiol 284: F599-F607, 2003
37. Bader M: Role of the local renin-angiotensin system in cardiac damage: A minireview focussing on transgenic animal models. J Mol Cell Cardiol 34: 1455-1462, 2002
38. Van Kats JP, Methot D, Paradis P, Silversides DW, Reudelhuber TL: Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem 276: 44012-44017, 2001
39. Kon V, Jabs K: Angiotensin in atherosclerosis. Curr Opin Nephrol Hypertens 13: 291-297, 2004
40. Krege JH, Hodgin JB, Hagaman JR, Smithies O: A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25: 1111-1115, 1995